Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics Received A Letter From Nasdaq Stating That Co Has Regained Compliance With Minimum Bid Price Requirement

Jan 30 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS INC - ON JANUARY 29, RECEIVED A
LETTER
FROM NASDAQ STATING THAT CO HAS REGAINED COMPLIANCE WITH MINIMUM
BID PRICE REQUIREMENT

Source text for Eikon:  ID:n0001193125-24-018799 
Further company coverage:  EFTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news